<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03480555</url>
  </required_header>
  <id_info>
    <org_study_id>RC17/252/R</org_study_id>
    <nct_id>NCT03480555</nct_id>
  </id_info>
  <brief_title>Replacing Protein Via Enteral Nutrition in a Stepwise Approach in Critically Ill Patients</brief_title>
  <acronym>Replenish</acronym>
  <official_title>Replacing Protein Via Enteral Nutrition in a Stepwise Approach in Critically Ill Patients: Feasibility Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>King Abdullah International Medical Research Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>King Abdullah International Medical Research Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, we will explore the feasibility of a randomized controlled trial that will
      compare high protein dose from ICU day 6 to 14 with moderate protein intake.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients will be recruited on day 1-2 of ICU admission. On day 5, patients will be randomized
      into one of the two intervention arms;

      Replenish Protein group:

      Patients randomized to this group will receive 2 g of protein/kg/day (acceptable range 1.8 -
      2.2 g of protein/kg/day) for day 6-14.

      Standard Protein group:

      Patients randomized to this group will receive protein at 0.8 - 1.0 g of protein/kg/day for
      day 6-14
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 16, 2018</start_date>
  <completion_date type="Actual">September 10, 2019</completion_date>
  <primary_completion_date type="Actual">May 10, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Recruitment</measure>
    <time_frame>6 months</time_frame>
    <description>Recruitment log</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Retention rate</measure>
    <time_frame>14 days</time_frame>
    <description>withdrawals</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Achieved protein intake</measure>
    <time_frame>14 days</time_frame>
    <description>Feeding data</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Functional assessment</measure>
    <time_frame>28 days</time_frame>
    <description>Anthropometric measurement and Medical Research Council (MRC)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional assessment</measure>
    <time_frame>90 days</time_frame>
    <description>SF-36 form,</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Critical Illness</condition>
  <condition>ARDS</condition>
  <condition>Septic Shock</condition>
  <condition>Multiple Trauma</condition>
  <condition>Seizure Disorder</condition>
  <condition>Hemorrhagic Shock</condition>
  <arm_group>
    <arm_group_label>Replenish Protein group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects randomized to this group will receive 2 g of protein/kg/day (acceptable range as 1.8 - 2.2 g of protein/kg/day) for day 6-14.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard Protein group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Subjects randomized to this group will receive 0.8 - 1 g of protein/kg/day for day 6-14</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Replenish Protein</intervention_name>
    <description>Subjects randomized to this group will receive 2 g of protein/kg/day (acceptable range as 1.8 - 2.2 g of protein/kg/day) for day 6-14.</description>
    <arm_group_label>Replenish Protein group</arm_group_label>
    <other_name>Intervention group</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Standard protein</intervention_name>
    <description>Subjects randomized to this group will receive 0.8 - 1 g of protein/kg/day for day 6-14</description>
    <arm_group_label>Standard Protein group</arm_group_label>
    <other_name>Control group</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria

          1. Age ≥ 18 years

          2. Mechanically ventilated

          3. Receiving enteral feeding via nasogastric/orogastric or duodenal or PEG or jejunostomy
             tubes and

          4. Expected to stay ≥ 1 week in the ICU

        Exclusion criteria

          1. Lack of commitment to ongoing life support, which includes;

               -  Terminal Illness (Malignancy or irreversible condition with 6 month mortality &gt;
                  50%)

               -  DNR order in the first 48 hours and brain death within 48 hours of admission)
                  (Don't include the presence of a &quot;Do Not Resuscitate&quot; order alone, if there is a
                  commitment to ongoing life support).

          2. Patients not fed within 48 hours of admission

          3. Patients on total parenteral nutrition (TPN)

          4. Patients being fed orally

          5. Chronic renal failure

          6. Chronic liver disease

          7. Renal replacement therapy

          8. Pregnancy.

          9. Kidney transplant

         10. Post-liver transplant.

         11. Post cardiac arrest.

         12. Burn patients.

         13. Prisoners

        Screened patients will be screened again for eligibility at day 5, should be mechanically
        ventilated and expected to stay ≥ 3 days in the ICU. At this point, patients will be
        excluded if they meet the following;

          1. New onset renal replacement therapy.

          2. Acute Kidney Injury (serum creatinine &gt; 3 times the preacute level or serum creatinine
             &gt;350mmol/L with a recent increase of &gt;44 mmols/L)

          3. Significant liver impairment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yaseen M Arabi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>King Abdulaziz Medical City-Ministry of National Guard</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>King Abdulaziz Medical city</name>
      <address>
        <city>Jeddah</city>
        <zip>21423</zip>
        <country>Saudi Arabia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>King Abdulaziz Medical city</name>
      <address>
        <city>Riyadh</city>
        <zip>11426</zip>
        <country>Saudi Arabia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Saudi Arabia</country>
  </location_countries>
  <results_reference>
    <citation>McClave SA, Taylor BE, Martindale RG, Warren MM, Johnson DR, Braunschweig C, McCarthy MS, Davanos E, Rice TW, Cresci GA, Gervasio JM, Sacks GS, Roberts PR, Compher C; Society of Critical Care Medicine; American Society for Parenteral and Enteral Nutrition. Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenter Enteral Nutr. 2016 Feb;40(2):159-211. doi: 10.1177/0148607115621863. Erratum in: JPEN J Parenter Enteral Nutr. 2016 Nov;40(8):1200.</citation>
    <PMID>26773077</PMID>
  </results_reference>
  <results_reference>
    <citation>Arabi YM, Aldawood AS, Solaiman O. Permissive Underfeeding or Standard Enteral Feeding in Critical Illness. N Engl J Med. 2015 Sep 17;373(12):1175-6. doi: 10.1056/NEJMc1509259.</citation>
    <PMID>26376142</PMID>
  </results_reference>
  <results_reference>
    <citation>Arabi YM, Casaer MP, Chapman M, Heyland DK, Ichai C, Marik PE, Martindale RG, McClave SA, Preiser JC, Reignier J, Rice TW, Van den Berghe G, van Zanten ARH, Weijs PJM. The intensive care medicine research agenda in nutrition and metabolism. Intensive Care Med. 2017 Sep;43(9):1239-1256. doi: 10.1007/s00134-017-4711-6. Epub 2017 Apr 3. Review.</citation>
    <PMID>28374096</PMID>
  </results_reference>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 22, 2018</study_first_submitted>
  <study_first_submitted_qc>March 21, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 29, 2018</study_first_posted>
  <last_update_submitted>February 19, 2020</last_update_submitted>
  <last_update_submitted_qc>February 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Enteral nutrition, Intensive Care Units, caloric restriction, infections, insulin, mortality, protein catabolism, NUTRIC score</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Seizures</mesh_term>
    <mesh_term>Epilepsy</mesh_term>
    <mesh_term>Shock</mesh_term>
    <mesh_term>Critical Illness</mesh_term>
    <mesh_term>Shock, Hemorrhagic</mesh_term>
    <mesh_term>Multiple Trauma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Data will be shared with the other participating sites after the completion of the main study and upon the descretion of the study Principle investigator only</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

